- Home
- HSCS
as of 08-21-2026 2:22pm EST
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | SOUTHLAKE |
| Market Cap: | 6.4M | IPO Year: | 2022 |
| Target Price: | $8.00 | AVG Volume (30 days): | 62.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | semi-annual |
| EPS: | -2.10 | EPS Growth: | 50.84 |
| 52 Week Low/High: | $1.63 - $3.80 | Next Earning Date: | 03-16-2026 |
| Revenue: | $4,319 | Revenue Growth: | -0.71% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
| P/E Ratio: | -1.19 | Index: | N/A |
| Free Cash Flow: | -7430261.0 | FCF Growth: | N/A |
AI-Powered HSCS Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Earnings Transcripts
SEC 8-K filings with transcript text
2026 Q2 Q2 2026 Earnings
8-K SELL Jul 29, 2026 · 100% conf.
Q2 2026 Earnings
8-K SELLJul 29, 2026 · 100% conf.
1D
-1.57%
$2.13
Act: -3.70%
5D
-14.06%
$1.86
Act: +5.56%
20D
-12.11%
$1.90
Transcript text not available. View on SEC.gov →
2025 Q4 Q4 2025 Earnings
8-K Mar 16, 2026
Q4 2025 Earnings
8-KMar 16, 2026
2025 Q3 Q3 2025 Earnings
8-K Dec 15, 2025
Q3 2025 Earnings
8-KDec 15, 2025
2025 Q2 Q2 2025 Earnings
8-K Sep 11, 2025
Q2 2025 Earnings
8-KSep 11, 2025
2025 Q2 Q2 2025 Earnings
8-K Jul 24, 2025
Q2 2025 Earnings
8-KJul 24, 2025
2024 Q4 Q4 2024 Earnings
8-K Mar 13, 2025
Q4 2024 Earnings
8-KMar 13, 2025
2024 Q3 Q3 2024 Earnings
8-K Dec 16, 2024
Q3 2024 Earnings
8-KDec 16, 2024
2024 Q2 Q2 2024 Earnings
8-K Sep 12, 2024
Q2 2024 Earnings
8-KSep 12, 2024
2024 Q2 Q2 2024 Earnings
8-K Jul 29, 2024
Q2 2024 Earnings
8-KJul 29, 2024
2023 Q4 Q4 2023 Earnings
8-K Mar 14, 2024
Q4 2023 Earnings
8-KMar 14, 2024
2023 Q3 Q3 2023 Earnings
8-K Dec 14, 2023
Q3 2023 Earnings
8-KDec 14, 2023
2023 Q2 Q2 2023 Earnings
8-K Sep 14, 2023
Q2 2023 Earnings
8-KSep 14, 2023
2023 Q2 Q2 2023 Earnings
8-K Jul 19, 2023
Q2 2023 Earnings
8-KJul 19, 2023
2022 Q4 Q4 2022 Earnings
8-K Mar 16, 2023
Q4 2022 Earnings
8-KMar 16, 2023
2022 Q3 Q3 2022 Earnings
8-K Dec 22, 2022
Q3 2022 Earnings
8-KDec 22, 2022
2022 Q2 Q2 2022 Earnings
8-K Sep 13, 2022
Q2 2022 Earnings
8-KSep 13, 2022
2022 Q2 Q2 2022 Earnings
8-K Aug 5, 2022
Q2 2022 Earnings
8-KAug 5, 2022
Compare HSCS vs Leading Stocks
See how HSCS stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "HSCS Heart Test Laboratories Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.